Clinical Trials Logo

Clinical Trial Summary

This study is a prospective comparison between absorbable hemostatic agents as a group and the body's natural hemostatic ability without aid of therapy in patients undergoing bilateral sinus surgery with or without septoplasty.


Clinical Trial Description

The purpose of this study is to evaluate the efficacy of absorbable hemostatic agents in comparison with physiologic hemostasis after endoscopic sinus surgery. The investigators aim to determine the relative efficacy of hemostatic agents to halt epistaxis and compare this with the degree of epistaxis observed without therapy and evaluate objective healing parameters. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03068728
Study type Interventional
Source St. Louis University
Contact
Status Completed
Phase N/A
Start date May 13, 2014
Completion date April 10, 2017

See also
  Status Clinical Trial Phase
Completed NCT05984004 - Safety Evaluation of Intranasal Use of DSM 32444 Postbiotic in Humans N/A